<p>To further explore some more aggressive subtypes in pediatric cancer already under study in OCG, CGCI is partnering with TARGET initiative to support extensive sequencing analysis of three hard to  treat childhood cancers: refractory to treatment cases of acute myeloid leukemia and two rare kidney tumors; clear cell sarcoma of the kidney and</p>

TARGET: Kidney, Rhabdoid Tumor (RT)

Rhabdoid Tumor study with Bisulfite-Seq, ChIP-Seq + 3 more data on CRDC (70 participants)